BZYR
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
6.31M
CRNX
Price
$30.99
Change
+$0.58 (+1.91%)
Updated
Jul 25 closing price
Capitalization
2.9B
11 days until earnings call
Interact to see
Advertisement

BZYR vs CRNX

Header iconBZYR vs CRNX Comparison
Open Charts BZYR vs CRNXBanner chart's image
Burzynski Research Institute
Price$0.05
Change-$0.00 (-0.00%)
Volume$2.5K
Capitalization6.31M
Crinetics Pharmaceuticals
Price$30.99
Change+$0.58 (+1.91%)
Volume$737.32K
Capitalization2.9B
BZYR vs CRNX Comparison Chart in %
Loading...
BZYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BZYR vs. CRNX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BZYR is a StrongBuy and CRNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BZYR: $0.05 vs. CRNX: $30.41)
Brand notoriety: BZYR and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BZYR: 47% vs. CRNX: 0%
Market capitalization -- BZYR: $6.31M vs. CRNX: $2.9B
BZYR [@Biotechnology] is valued at $6.31M. CRNX’s [@Biotechnology] market capitalization is $2.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BZYR’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • BZYR’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, BZYR is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BZYR’s TA Score shows that 5 TA indicator(s) are bullish while CRNX’s TA Score has 4 bullish TA indicator(s).

  • BZYR’s TA Score: 5 bullish, 3 bearish.
  • CRNX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BZYR is a better buy in the short-term than CRNX.

Price Growth

BZYR (@Biotechnology) experienced а +5.87% price change this week, while CRNX (@Biotechnology) price change was -2.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

BZYR is expected to report earnings on May 20, 2025.

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.9B) has a higher market cap than BZYR($6.31M). BZYR YTD gains are higher at: 54.839 vs. CRNX (-40.524). BZYR has higher annual earnings (EBITDA): -1.46M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. BZYR (613). CRNX has higher revenues than BZYR: CRNX (760K) vs BZYR (0).
BZYRCRNXBZYR / CRNX
Capitalization6.31M2.9B0%
EBITDA-1.46M-373.49M0%
Gain YTD54.839-40.524-135%
P/E RatioN/AN/A-
Revenue0760K-
Total Cash6131.27B0%
Total DebtN/A50.8M-
FUNDAMENTALS RATINGS
BZYR vs CRNX: Fundamental Ratings
BZYR
CRNX
OUTLOOK RATING
1..100
7353
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10071
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
3964
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRNX's Valuation (91) in the Pharmaceuticals Major industry is in the same range as BZYR (98) in the null industry. This means that CRNX’s stock grew similarly to BZYR’s over the last 12 months.

CRNX's Profit vs Risk Rating (71) in the Pharmaceuticals Major industry is in the same range as BZYR (100) in the null industry. This means that CRNX’s stock grew similarly to BZYR’s over the last 12 months.

CRNX's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as BZYR (100) in the null industry. This means that CRNX’s stock grew similarly to BZYR’s over the last 12 months.

BZYR's Price Growth Rating (39) in the null industry is in the same range as CRNX (64) in the Pharmaceuticals Major industry. This means that BZYR’s stock grew similarly to CRNX’s over the last 12 months.

BZYR's P/E Growth Rating (100) in the null industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that BZYR’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BZYRCRNX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BZYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCHL26.705.15
+23.90%
Scholastic Corp
SOHO0.880.01
+0.83%
Sotherly Hotels
COF211.33N/A
N/A
Capital One Financial
LSAK4.25-0.02
-0.47%
Lesaka Technologies
MGY23.74-0.24
-1.00%
Magnolia Oil & Gas Corp

BZYR and

Correlation & Price change

A.I.dvisor tells us that BZYR and DWTX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BZYR and DWTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BZYR
1D Price
Change %
BZYR100%
N/A
DWTX - BZYR
29%
Poorly correlated
+0.85%
CRNX - BZYR
21%
Poorly correlated
N/A
RENB - BZYR
20%
Poorly correlated
-5.13%
BVNRY - BZYR
10%
Poorly correlated
+0.33%
BIXT - BZYR
1%
Poorly correlated
-6.37%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
N/A
XNCR - CRNX
61%
Loosely correlated
N/A
IDYA - CRNX
58%
Loosely correlated
-1.33%
TRDA - CRNX
57%
Loosely correlated
+2.35%
RVMD - CRNX
56%
Loosely correlated
+1.84%
KRYS - CRNX
55%
Loosely correlated
-1.59%
More